Bridgeway Capital Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-27,224
| Closed | -$610K | – | 1428 |
|
|
2019
Q1 | $610K | Sell |
27,224
-16,000
| -37% | -$359K | 0.01% | 963 |
|
|
2018
Q4 | $787K | Hold |
43,224
| – | – | 0.01% | 832 |
|
|
2018
Q3 | $782K | Buy |
43,224
+2,224
| +5% | +$40.2K | 0.01% | 997 |
|
|
2018
Q2 | $408K | Hold |
41,000
| – | – | ﹤0.01% | 1191 |
|
|
2018
Q1 | $218K | Buy |
+41,000
| New | +$218K | ﹤0.01% | 1261 |
|